Global Newcastle Disease Vaccine Market is valued at USD 298.7 Million in 2021 and is expected to reach USD 374.9 Million by 2028 with a CAGR of 3.3% over the forecast period.
Global Newcastle Disease Vaccine Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2022-2028- Rising demand for poultry health coupled with the increasing poultry headcount and increasing prevalence of zoonotic diseases in poultry are driving the growth of the Global Newcastle disease vaccine market.
Over the last few years, hens have been plagued by a number of infectious diseases. The most serious of these is the viral disease known as Newcastle disease, which causes severe damage to commercial and village hens in the last few years, killing millions of hens. The use of Newcastle disease vaccine to reduce the damage caused to a large number of village hens by viral Newcastle disease is a necessary and the best first step to improving their productivity. Newcastle disease has been shown to be controlled by the use of the Newcastle disease vaccine. There are several Newcastle disease vaccines currently available in the market for use in commercial hens. They are also available in the international market. The I-2 Newcastle disease vaccine has been developed exclusively for local or regional production and is being used to control Newcastle disease in village hens.
The outbreak of Covid-19 has certainly affected the global Newcastle disease vaccine market. The lockdown has forced veterinarians to close their operations, or even if the vet is open, in the meantime people were afraid to go to the veterinarian for vaccinations. As a result, the market for the Newcastle disease vaccine has declined significantly in 2020. Strict regulations on animal vaccination to prevent the spread of the disease after the Covid-19 pandemic are expected to boost the market growth in the next few years.
The key players for global Newcastle disease vaccine market include
The Global Newcastle disease vaccine market is segmented into type, species, and region & country level. On the basis of type, the Newcastle disease vaccine market is segmented into live vaccine and killed vaccine. On the basis of species, the Newcastle disease vaccine market is segmented into chicken, duck & goose and other.
The regions covered in this global Newcastle disease vaccine market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of global Newcastle disease vaccine is sub divided into U.S., Mexico, Canada, UK, France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Regulators are now accelerating the process of approving various vaccines related to veterinary health; these factors are driving the growth of the Newcastle disease vaccine market. Increasing number of poultry rearing, the demand for vaccines for its care is also increasing. As a result, the market for Newcastle disease vaccines is growing exponentially. Poultry rearing has increased significantly in many countries over the last few years. In India, a large number of young people are turning to this industry at present. According to the 20th Livestock Census, there is 851.8 million poultry in India. About 30 percent (250 million) of these are backyard poultry or small and marginal farmers. According to the 19th Livestock Census, the number of such farmers is around 30 million. And also, in 2019, mainland China had more than 5.14 billion hens living, more than any other country in the world. According to the Food and Agriculture Organization (FAO). The number of chickens, which was 14.38 billion in 2000, will reach 25.9 billion in 2019. The largest share of this presentation is from Asian countries. During the same period, the total chicken presence in Asia was 15.8 billion. The United States is next with 5.8 billion. The presence of chickens in Africa and Europe is 2 billion each. Due to this increasing number of poultry farms, the demand for Newcastle disease vaccines is increasing in the market.
In addition, increasing demand for livestock consumption and rising number of diseases area also fostering the market growth. For example; according to the Department of Agriculture, Water and the Environment; global meat consumption increased by 58% over the 20 years to 2018 to reach 360 million tonnes. Population growth accounted for 54% of this increase and per person consumption growth accounted for the remainder. In the 20 years to 2018 developing countries accounted for around 85% of the rise in global meat consumption.
However, lack of awareness regarding the disease and vaccine especially in emerging economies may hamper the market growth. In spite of that, increasing adoption and rising advancements in this field may create more opportunities for the further growth of the market.
The North American is expected to dominate the global Newcastle disease vaccine market during the forecast period owing to the increasing consumption of poultry-related foods, high prevalence of avian diseases, and consumer perception of food security are in this region, especially in the US; moreover, poultry meat production has played a significant role. According to The Humane League; the over time, meat consumption and consumption in the United States has gradually increased, along with production. Between 1961 and 2018, annual meat production increased by over 30 million tonnes, representing an increase of 184%. Furthermore, the adoption of the country's poultry vaccines is being driven by joint strategic projects and acquisitions to improve bird health which is also supplementing the market growth.
Market value is expected to rise sharply in the Asia-Pacific region. Asia-Pacific countries have heterogeneous classes of economic development, which results in different approaches to vaccination. Japan is expected to capture the major share of the Asia-Pacific market. In Europe, on the other hand, the market is expected to grow steadily. High-growth countries such as Germany and France are expected to contribute to the expansion of the European market.
On March 18th, 2019; Merck Animal Health, a division of Merck & Co, announced the launch of INNOVAX ND-ILT for Infectious and Untreated Diseases, which protects poultry against three highly contagious diseases; Newcastle Disease (ND), Infectious Laryngotrachitis (ILT), and Marek Disease (MD) when fed to chickens under the skin in an oven or hatchery.
On November 7th, 2018; Merck Animal Health announced the company launched the first live poultry vaccine, INNOVAX-ND-IBD, in the US to combat multiple and untreated diseases. Biotechnology protects poultry from three highly contagious diseases - Newcastle Disease (ND), Infectious Bursal Disease (IBD), and Marek Disease (MD). This vaccine provides simultaneous protection against ND, IBD, and MD when given to subcutaneous hens in the ovary or hatchery.
|Historical data||2015 - 2020|
|Forecast Period||2021 - 2028|
|Market Size in 2021:||USD 298.7 Million|
|Base year considered||2020|
|Forecast Period CAGR %:||3.3%|
|Market Size Expected in 2028:||USD 374.9 Million|
|Tables, Charts & Figures:||175|
|Newcastle Disease Vaccine Companies||FATRO, Merck Animal Health, Vaksindo, Kyoto Biken, Yebio, HVRI, CAVAC, Merial, ChengDu Tecbond, Sindh Poultry Vaccine Centre, CEVA, DHN, QYH Biotech, Elanco, Ringpu Biology, Zoetis, and others.|
|Segments Covered||By Type, By Species|
|Regional Analysis||North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa|
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us email@example.comJOIN US
BrandEssence® Market Research and Consulting Pvt ltd.
Kemp House, 152 - 160 City Road, London EC1V 2NX
© Copyright 2022-23 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®